14.700
+0,00%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -44.5% | -28.3% | 0 / 3 | +10.9% | -4.92 pp | -4.65 pp | +9.1% | 0.40 | 7.55 | 968 | +10,9% | 45,8 | −44,1% | 7.55 | 11.92 | −36,7% |
| Pts | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 14.700 (close price on 2026-10-19)EPS (TTM): 1.947
Financial charts
1.Revenue & growth
VND bn968Q2/26
1.Revenue & growth
VND bn968Q2/26
2.Profit & growth
VND bn45,1Q2/26
3.Profit mix (Penman)
VND bn277Q2/26
4.Margins & cost structure
%14.8%Q2/26
5.Returns & cash cycle
% · days9.1%Q2/26
6.Earnings quality & cash
VND bn465Q2/26
7.Asset structure
VND bn4.270Q2/26
8.Funding & debt health
VND bn · times4.270Q2/26
9.Revenue backlog
VND bn42,6Q2/26
10.Valuation
times · %7,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %383Q2/26
Adjusted EPS growth, latest quarter
-44.6%
Average adjusted EPS growth, 3 quarters
-28.4%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26